GFAP IHC Test for Nervous System Tumors | Lahalak
An essential test for diagnosing central nervous system tumors, helping differentiate gliomas to ensure accurate diagnosis and effective treatment planning.
Scientific name: Immunohistochemistry: Glial Fibrillary Acidic Protein (GFAP)
Immunohistochemical assays for glial fibrillary acidic protein (GFAP) are used to detect this fibrillar intermediate protein, a major component of the scaffold of astrocytes and glial derivatives in the central and peripheral nervous systems. GFAP is a highly specific and sensitive marker for identifying glial cell tumors (gliomas) such as astrocyt...
Service type
Histopathology Laboratory Test
Duration
30-45 minutes
Fasting
Fasting is not required
Included Services
- Detailed analysis for the detection of GFAP protein in central nervous system tissue samples
- Consult a neuropathologist to interpret the results.
- Personal support services from Lahalak
Medical Service Information
Conditions & Notices
- Fasting is not required, as the sample is a surgical tissue sample from the brain or spinal cord.
- It is necessary to preserve the tissue sample immediately in 10% formalin to preserve the fine structures of the nerve and glial cells.
- This analysis is often requested as part of a diagnostic package for central nervous system tumors, which includes markers such as Olig2, IDH1 R132H, ATRX, and p53.
- Attach information about the location of the tumor within the nervous system and the results of the magnetic resonance imaging (MRI).
Medical services you might also like
